Fetal Lung MRI (NANO)
Research type
Research Study
Full title
The use of Advanced MRI techniques to evaluate antenatal lung development (NANO: MRI aNd Antenatal luNg develOpment)
IRAS ID
309047
Contact name
Reza Rezavi
Contact email
Sponsor organisation
King's College London
Clinicaltrials.gov Identifier
na, na
Duration of Study in the UK
2 years, 11 months, 30 days
Research summary
Inadequate development of the lungs (known as pulmonary hypoplasia) is a relatively common event, occurring in 1 in 1000 pregnancies. In 50% of these babies the lungs are too small for long term survival after birth. Risk factors include rupture of the membranes before twenty-four weeks with loss of the amniotic fluid surrounding the baby or the presence of a congenital abnormality of the baby’s heart or chest
At present, in clinical practice, the size of the baby’s lungs can be evaluated during the pregnancy using either ultrasound or basic magnetic resonance imaging (MRI ). The latter are safe scans which use magnets to create images of the baby. Estimated size gives some information about whether a baby will survive after birth but neither of these assessments provide detailed information about alterations in lung development such as how the air spaces are forming or indicate how the lungs might function after birth. Advanced MRI techniques could provide more in depth information about both normal and abnormal lung development.
This study will use these advanced MRI techniques to see how babies’ lungs develop in the womb during normal pregnancies (100 pregnancies). We will then assess 70 pregnancies at high risk of pulmonary hypoplasia to assess the specific alterations in lung development that occur in this condition.
All women will undergo an MRI scan during their pregnancy. In women with uncomplicated pregnancies this will be once during the pregnancy between 16 and 42 weeks of pregnancy. In women with pregnancies at risk of pulmonary hypoplasia we will perform two MRI scans, one when we identify them as high risk and another later in the pregnancy. We will collect information on the babies after birth such as if they survive, need oxygen or other treatments to help them breathe. After birth we will also assess how the lungs are functioning using a technique called helium dilution. During this safe test the baby breathes in helium (a non-harmful gas) which allows us to calculate the actual size of the babies’ lungs.
In the future this new knowledge may help individualise counselling as to how a baby’s lungs are likely to function after birth. Currently women who lose the waters around the baby early in the pregnancy or have other abnormalities with the chest or heart are given the option of termination of pregnancy due to the high risk of pulmonary hypoplasia however some children do survive although with varying qualities of life. These new MRI scans may also help to monitor potential treatments aimed at improving lung growth and development such as surgery or medications administered in the womb.
REC name
Yorkshire & The Humber - South Yorkshire Research Ethics Committee
REC reference
22/YH/0210
Date of REC Opinion
4 Oct 2022
REC opinion
Favourable Opinion